Keywords: Arena Pharma, Lorcaserin, Lorquess, Vivus, Qnexa, Obesity, Weight-loss, USA, FDA, Eisai

FDA updates on obesity drug candidates

Article | 11 January 2012

Print This

There have been two pieces of positive news coming out of the US Food and Drug Administration this week relating ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in